ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    Body Mass Index >35 Does Not Impact Kidney Transplant Outcomes or Health Related Quality of Life Despite BMI Class or Recipient Race

    D. A. Walczak1, E. Collins2, E. Benedetti1

    1Organ Transplant, University of Il Hospital and Health Sciences System, Chicago, IL, 2College of Nursing, Dept of Bio-behavioral Health Science, University of Illinois at Chicago, Chicago, IL

    *Purpose: Kidney transplant [KTx] in recipients with BMI > 35 remains controversial and has not often been studied in recipients with BMI >40. There is…
  • 2021 American Transplant Congress

    Is Low Systemic Fibrinolytic Activity During the Anhepatic Phase Liver Transplant Surgery Associate with the Dreaded Post-Operative Complication of Hepatic Artery Thrombosis?

    H. B. Moore1, Y. Bababekov1, J. Pomposelli1, T. Ferrell1, F. Azam1, M. Adams2, D. Yoeli1, R. Choudhury1, M. Wachs2, E. Pomfret1, T. Nydam1

    1University of Colorado, Aurora, CO, 2Childrens Hospital Colorado, Aurora, CO

    *Purpose: Removal of the native liver during transplantation results in impaired clearance of clot degrading proteins and activation of fibrinolysis as appreciated by Starzl in…
  • 2021 American Transplant Congress

    Bamlanivimab for Covid-19 in Kidney Transplant Patients

    M. Y. Jan, S. El-Sayegh, M. S. Yaqub, D. P. Mishler, O. Adebiyi, M. D. Anderson, T. E. Taber, A. Sharfuddin

    Nephrology, Indiana University School of Medicine, Indianapolis, IN

    *Purpose: Treatment options for patients with COVID 19 have limited efficacy in reducing severity and duration of viral symptoms as well as progression to severe…
  • 2021 American Transplant Congress

    Early Increases in Post-Transplant Pancreatic Enzymes are Not Associated with Inferior Patient or Graft Outcomes Among Pancreas Transplant Recipients

    S. Parajuli, G. E. Leverson, B. Welch, H. Sollinger, D. Kaufman, D. Mandelbrot, J. Odorico

    University of Wisconsin, Madison, WI

    *Purpose: An increase in the serum concentration of pancreatic enzymes (amylase and lipase) is commonly related to an acute inflammatory process in the pancreas graft…
  • 2021 American Transplant Congress

    Utilization of Pre-Procurement Donor Liver Biopsy in Donation-after-circulatory-Death Liver Transplantation

    A. C. Bolognese1, N. Neidlinger1, C. Sparks2, A. Schneider2, A. M. D'Alessandro1, D. P. Foley1

    1Department of Surgery, Division of Transplantation, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2UW Organ and Tissue Donation, Madison, WI

    *Purpose: Careful selection of suitable DCD donor livers is critical to obtain optimal transplant outcomes. In order to identify potentially suitable livers prior to DCD…
  • 2021 American Transplant Congress

    A Comparison Between Combined Liver Kidney Transplants to Liver Transplants Alone: A Systematic Review and Meta-analysis

    S. Bouari1, E. A. Rijkse1, H. J. Metselaar2, M. W. van den Hoogen3, J. N. Ijzermans1, J. de Jonge1, W. G. Polak1, R. C. Minnee1

    1Surgery, Division of HPB & Transplant Surgery, Erasmus MC, Rotterdam, Netherlands, 2Gastroenterology and Hepatology, Erasmus MC, Rotterdam, Netherlands, 3Internal Medicine, Section of Nephrology and Transplantation, Erasmus MC, Rotterdam, Netherlands

    *Purpose: Since the introduction of the Model for End-stage Liver disease (MELD) criteria in 2002, more combined liver kidney transplants are performed. Until 2017, no…
  • 2021 American Transplant Congress

    Pilot Evaluation of Prognosis After Liver Transplantation in Patients with a History of Hepatocellular Carcinoma and Pd-1 Inhibition

    M. Chen1, Z. Chen1, X. Lin2

    1First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 2the Eastern Hospital of the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    *Purpose: The successful applications of programmed death protein-1 (PD-1) inhibitors in cancer therapy has led to an expanding use of immunotherapy in oncolog Liver transplantation…
  • 2021 American Transplant Congress

    Recent Trends and Outcomes of Liver Transplantation for Non-alcoholic Steatohepatitis versus Alcohol Liver Disease in the United States: Obesity Might be Protective

    K. Okumura, I. Lee, H. Sogawa, G. Veillette, D. John, T. Diflo, R. Bodin, D. Wolf, S. Nishida

    Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY

    *Purpose: Nonalcoholic steatohepatitis (NASH) and alcohol liver disease (ALD) are rapidly growing indications for liver transplantation (LT). The recent trends and outcomes in NASH and…
  • 2021 American Transplant Congress

    Impact of Donation After Circulatory Death Donor Allografts on Outcomes Following Liver Transplantation for Cholangiocarcinoma

    S. Kumar1, S. Lin2, J. D. Schold2

    1Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, 2Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH

    *Purpose: Improvements in the management of extra-hepatic cholangiocarcinoma (CCA) resulted in allocation of a standardized model for end-stage liver disease (MELD) exception score for liver…
  • 2021 American Transplant Congress

    Machine Learning Informs Utility-Based Non-Directed Living Liver Donor Allocation

    K. Bambha1, J. Perkins1, M. Sturdevant1, S. W. Biggins1, R. Bakthavatsalam1, P. Healey2, A. Dick2, J. Reyes1

    1University of Washington, Seattle, WA, 2Seattle Children's, Seattle, WA

    *Purpose: To maximize non-directed living liver donor graft utility, we developed analytic models predicting 10-year graft survival post liver transplant (LT).*Methods: We analyzed OPTN living…
  • « Previous Page
  • 1
  • …
  • 215
  • 216
  • 217
  • 218
  • 219
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences